https://it.marketscreener.com/quotazioni/azione/JW-CAYMAN-THERAPEUTICS-CO-119080133/attualita/JW-Therapeutics-annuncia-l-approvazione-IND-per-la-sperimentazione-clinica-di-Relma-cel-nei-pazienti-43464474/?utm_source=telegram&utm_medium=social&utm_campaign=share